A 12-year population-based study of psychosis in parkinson disease. FDA approves first drug to treat hallucinations and delusions associated with Parkinson’s disease.įorsaa EB, Larsen JP, Wentzel-Larsen T, et al. A guide for understanding Parkinson’s disease psychosis hallucinations & delusions.įood and Drug Administration. The efficacy and safety of antipsychotic medications in the treatment of psychosis in patients with Parkinson’s disease.
0 Comments
Leave a Reply. |